These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 6763955

  • 1. [Bladder carcinogenesis and tryptophan metabolism].
    Matsushima M.
    Nihon Hinyokika Gakkai Zasshi; 1982 Dec; 73(12):1511-5. PubMed ID: 6763955
    [No Abstract] [Full Text] [Related]

  • 2. Tryptophan and carcinogenesis: review and update on how tryptophan may act.
    Sidransky H.
    Nutr Cancer; 1997 Dec; 29(3):181-94. PubMed ID: 9457738
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Tryptophan urinary bladder absorption and bladder cancer.
    Flanagan MJ, Ekbal S, Coogan PS, Kalin G, Hass GM.
    Invest Urol; 1975 Jul; 13(1):17-9. PubMed ID: 1140915
    [Abstract] [Full Text] [Related]

  • 5. Studies on the role of tryptophan metabolites in the genesis of bladder cancer.
    Wolf H.
    Acta Chir Scand Suppl; 1973 Jul; 433():154-68. PubMed ID: 4513505
    [No Abstract] [Full Text] [Related]

  • 6. Bladder cancer.
    Price JM.
    Proc Can Cancer Conf; 1966 Jul; 6():224-43. PubMed ID: 5339766
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of L-tryptophan excess and vitamin B6 deficiency on rat urinary bladder cancer promotion.
    Birt DF, Julius AD, Hasegawa R, St John M, Cohen SM.
    Cancer Res; 1987 Mar 01; 47(5):1244-50. PubMed ID: 3815336
    [Abstract] [Full Text] [Related]

  • 11. Tryptophan, urinary quinolines, and bladder cancer.
    Williams DJ.
    Nutr Cancer; 1988 Mar 01; 11(2):81-2. PubMed ID: 3283708
    [No Abstract] [Full Text] [Related]

  • 12. Promotion in bladder cancer.
    Hicks RM.
    Carcinog Compr Surv; 1982 Mar 01; 7():139-53. PubMed ID: 7039826
    [No Abstract] [Full Text] [Related]

  • 13. Studies on tryptophan metabolism in bilharzial bladder cancer patients.
    Abdel-Tawab GA, Ibrahim EK, el-Masri A, al-Ghorab M, Makhyoun N.
    Invest Urol; 1968 May 01; 5(6):591-601. PubMed ID: 5743558
    [No Abstract] [Full Text] [Related]

  • 14. [The role of L-tryptophan's promoting factor on tumorgenesis in the urinary bladder. 2. Urinary bladder carcinogenicity of FANFT (initiating factor) and L-tryptophan (promoting factor) in mice (author's transl)].
    Matsushima M.
    Nihon Hinyokika Gakkai Zasshi; 1977 Aug 01; 68(8):731-6. PubMed ID: 916452
    [No Abstract] [Full Text] [Related]

  • 15. Studies on tryptophen metabolism in patients with bladder cancer.
    Gailani S, Murphy G, Kenny G, Nussbaum A, Silvernail P.
    Cancer Res; 1973 May 01; 33(5):1071-7. PubMed ID: 4703119
    [No Abstract] [Full Text] [Related]

  • 16. Possible roles of excess tryptophan metabolites in cancer.
    Chung KT, Gadupudi GS.
    Environ Mol Mutagen; 2011 Mar 01; 52(2):81-104. PubMed ID: 20839220
    [Abstract] [Full Text] [Related]

  • 17. [Modelling bladder tumors in in vivo and in vitro experiments].
    Vlasov NN, Pliss GB, Khudoleĭ VV.
    Vopr Onkol; 1980 Mar 01; 26(5):99-105. PubMed ID: 7385721
    [No Abstract] [Full Text] [Related]

  • 18. Urinary bladder carcinogenesis: initiation-promotion.
    Cohen SM.
    Semin Oncol; 1979 Jun 01; 6(2):157-60. PubMed ID: 482957
    [No Abstract] [Full Text] [Related]

  • 19. Studies on tryptophan metabolism in Danish bladder cancer patients.
    Wolf H, Brown RR, Nyholm K.
    Acta Vitaminol Enzymol; 1975 Jun 01; 29(1-6):117-22. PubMed ID: 1244080
    [Abstract] [Full Text] [Related]

  • 20. [Disorders of tryptophan metabolism in bladder neoplasms].
    Martynenko AG, Kartasheva LA, Goĭkhberg MI, Klimenko IA.
    Vopr Onkol; 1972 Jun 01; 18(5):23-6. PubMed ID: 5043965
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.